As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to U.S. Congress in February 2022 about the PREVENT Pandemics Act Discussion Draft can be found below.
As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to U.S. Congress in February 2022 about the PREVENT Pandemics Act Discussion Draft can be found below.